Intellia Therapeutics, Inc.
USD16.42
-0.19 (-1.12%)
CEO
John Leonard
IPO Date
2016-05-06
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$16.57
Prev. Close
$16.61
Day Low
$16.02
Day High
$16.73
52W Low
$7.95
52W High
$28.25
Market Cap
$1.84B
Volume
0.81M
| -2.2 |
| 31 Dec 2023 | FY | 75.3% | -1326.5% | -45.8% | -37.0% | 0.11 | 8.67 | -5.6 |
| 31 Dec 2022 | FY | 85.5% | -909.8% | -38.4% | -31.2% | 0.11 | 9.61 | -5.7 |
| 31 Dec 2021 | FY | 79.2% | -810.5% | -25.8% | -20.7% | 0.07 | 6.11 | -31.3 |
| 31 Dec 2020 | FY | -159.4% | -231.5% | -25.5% | -19.8% | 0.07 | 9.59 | -22.7 |
| 31 Dec 2019 | FY | -151.5% | -230.9% | -36.9% | -29.8% | 0.07 | 8.12 | -7.0 |
| 31 Dec 2018 | FY | -192.8% | -280.4% | -30.7% | -24.6% | 0.00 | 8.01 | -6.9 |
| 31 Dec 2017 | FY | -159.0% | -258.6% | -22.5% | -18.0% | 0.00 | 11.32 | -10.2 |
| 31 Dec 2016 | FY | -93.2% | -192.0% | -15.1% | -10.6% | 0.00 | 9.15 | -14.3 |
| -2.5 |
| 30 Sept 2025 | Q3 | -472.8% | -735.2% | -13.5% | -11.0% | 0.13 | 6.21 | -4.7 |
| 30 Jun 2025 | Q2 | 100.0% | -710.8% | -14.2% | -11.3% | 0.14 | 5.19 | -2.4 |
| 31 Mar 2025 | Q1 | 100.0% | -687.6% | -14.7% | -11.6% | 0.15 | 4.90 | -1.6 |
| 31 Dec 2024 | Q4 | 100.0% | -1001.2% | -14.8% | -10.8% | 0.24 | 5.77 | -2.3 |
| 30 Sept 2024 | Q3 | 100.0% | -1489.5% | -14.1% | -11.6% | 0.11 | 6.73 | -3.8 |
| 30 Jun 2024 | Q2 | 62.6% | -2112.6% | -15.1% | -12.3% | 0.11 | 7.21 | -3.7 |
| 31 Mar 2024 | Q1 | 91.3% | -371.3% | -10.4% | -8.5% | 0.11 | 9.03 | -6.0 |
| 31 Dec 2023 | Q4 | 228.6% | 6894.2% | -12.6% | -10.2% | 0.11 | 8.67 | -5.2 |